Biophotonics Market by Application (See-through Imaging, Inside Imaging, Spectromolecular, Surface Imaging, Microscopy, Light Therapy, Biosensors), Technology (In-vivo, In-vitro), End-use (Diagnostics, Therapeutic, Tests), & Geography - Global Forecast to 2020
Emergence of nanotechnology and significant technological advancements in the field of biophotonics are major market drivers
The global biophotonics market is expected to reach USD 50.18 billion by 2020, at a CAGR of 11.5% between 2015 and 2020. The biophotonics industry has witnessed tremendous technological improvements over the past few years. Major drivers identified for the growth of the biophotonics market are emergence of nanotechnology, significant technological advancements over the last few years, increase in the demand for home-based POC devices, and increasing population & growing lifestyle diseases. Major restraints are slow rate of commercialization, high cost involved in research and development, and reluctance toward the adoption of new treatment practices.
Surface imaging market is expected to grow at higher CAGR during the forecast period
The report provides a detailed segmentation of the biophotonics market based on various application areas which include see-through imaging, inside imaging, spectromolecular, surface imaging, microscopy, light therapy, biosensors, and others. The application in see-through imaging accounted for the largest market share of the total biophotonics market. However, the market for surface imaging t is expected to grow at the highest CAGR between 2015 and 2020.
Medical diagnostics has emerged as a largest market segment for biophotonics market in 2014
Based on the end use of the biophotonics technology, the market is segmented into medical diagnostics, medical therapeutics, tests & components, and other (non-medical) sectors. Medical diagnostics accounted for the largest share of in 2014. The biophotonics market in the following geographic regions has been included in the report - the Americas, Europe, Asia-Pacific, and Rest of the World (RoW). Out of these regions Americas market is expected to grow at a highest CAGR during the forecast period.
During this market study several interviews were conducted with industry leaders such as CEOs, VPs, directors, and marketing executives for key insights. Break-up of profile of primary participants for the report is as given below:
The global biophotonics market is expected to reach USD 50.18 billion by 2020, at a CAGR of 11.5% between 2015 and 2020. The biophotonics industry has witnessed tremendous technological improvements over the past few years. Major drivers identified for the growth of the biophotonics market are emergence of nanotechnology, significant technological advancements over the last few years, increase in the demand for home-based POC devices, and increasing population & growing lifestyle diseases. Major restraints are slow rate of commercialization, high cost involved in research and development, and reluctance toward the adoption of new treatment practices.
Surface imaging market is expected to grow at higher CAGR during the forecast period
The report provides a detailed segmentation of the biophotonics market based on various application areas which include see-through imaging, inside imaging, spectromolecular, surface imaging, microscopy, light therapy, biosensors, and others. The application in see-through imaging accounted for the largest market share of the total biophotonics market. However, the market for surface imaging t is expected to grow at the highest CAGR between 2015 and 2020.
Medical diagnostics has emerged as a largest market segment for biophotonics market in 2014
Based on the end use of the biophotonics technology, the market is segmented into medical diagnostics, medical therapeutics, tests & components, and other (non-medical) sectors. Medical diagnostics accounted for the largest share of in 2014. The biophotonics market in the following geographic regions has been included in the report - the Americas, Europe, Asia-Pacific, and Rest of the World (RoW). Out of these regions Americas market is expected to grow at a highest CAGR during the forecast period.
During this market study several interviews were conducted with industry leaders such as CEOs, VPs, directors, and marketing executives for key insights. Break-up of profile of primary participants for the report is as given below:
- By Company Type - Tier 1 – 35 %, Tier 2 – 40% and Tier 3 – 25%
- By Designation – C level – 35%, Director level – 25%, Others – 40%
- By Region – Americas - 43%, Europe – 19%, APAC – 29%, RoW – 9%
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATION
1.6 MARKET STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of primary interviews
2.2 FACTOR ANALYSIS
2.2.1 INTRODUCTION
2.2.2 DEMAND-SIDE ANALYSIS
2.2.2.1 Rapid growth in the elderly population
2.2.3 SUPPLY-SIDE ANALYSIS
2.2.3.1 Poor customer perception
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
2.3.2 TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 BIOPHOTONICS MARKET OVERVIEW
4.2 BIOPHOTONICS MARKET, BY END-USE AND GEOGRAPHY
4.3 GEOGRAPHIC SNAPSHOT OF THE BIOPHOTONICS MARKET
4.4 BIOPHOTONICS MARKET, BY TECHNOLOGY (2015 – 2020)
4.5 SEE-THROUGH IMAGING BIOPHOTONICS MARKET, BY REGION
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET SEGMENTATION
5.2.1 BIOPHOTONICS MARKET, BY APPLICATION
5.2.2 BIOPHOTONICS MARKET, TECHNOLOGY
5.2.3 BIOPHOTONICS MARKET, BY END USE
5.2.4 BIOPHOTONICS MARKET, BY GEOGRAPHY
5.3 MARKET DYNAMICS
5.3.1 DRIVERS
5.3.1.1 Emergence of Nanotechnology
5.3.1.2 Significant technological advancements over the last few years
5.3.1.3 Increase in the demand for home-based POC devices
5.3.1.4 Aging population and growing lifestyle diseases
5.3.2 RESTRAINTS
5.3.2.1 Slow rate of commercialization
5.3.2.2 High cost involved in research and development
5.3.2.3 Reluctance toward the adoption of new treatment practices
5.3.3 OPPORTUNITIES
5.3.3.1 Emerging markets in the developing countries
5.3.3.2 The use of biophotonics in non-medical sectors
5.3.4 CHALLENGES
5.3.4.1 Government regulations and long certification & approval cycles
5.3.4.2 Pricing pressure in the point-of-care market
6 INDUSTRY INSIGHTS
6.1 INTRODUCTION
6.2 VALUE CHAIN ANALYSIS
6.3 INDUSTRY TRENDS
6.4 PORTER’S FIVE FORCES ANALYSIS
6.4.1 BARGAINING POWER OF SUPPLIERS
6.4.2 BARGAINING POWER OF BUYERS
6.4.3 THREAT OF NEW ENTRANTS
6.4.4 THREAT OF SUBSTITUTES
6.4.5 DEGREE OF COMPETITION
6.5 PEST ANALYSIS
6.5.1 POLITICAL FACTORS
6.5.2 ECONOMIC FACTORS
6.5.3 SOCIAL FACTORS
6.5.4 TECHNOLOGICAL FACTORS
7 BIOPHOTONICS MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 SEE-THROUGH IMAGING
7.3 INSIDE IMAGING (ENDOSCOPY)
7.4 SPECTROMOLECULAR
7.5 SURFACE IMAGING
7.6 MICROSCOPY
7.7 LIGHT THERAPY
7.8 BIOSENSORS
7.9 OTHERS
8 BIOPHOTONICS MARKET, BY TECHNOLOGY
8.1 INTRODUCTION
8.2 IN-VIVO
8.3 IN-VITRO
9 BIOPHOTONICS MARKET, BY END USE
9.1 INTRODUCTION
9.2 MEDICAL DIAGNOSTICS
9.3 MEDICAL THERAPEUTICS
9.4 TEST COMPONENTS
9.5 OTHER (NON-MEDICAL)
10 REGIONAL ANALYSIS
10.1 INTRODUCTION
10.2 AMERICAS
10.2.1 U.S.
10.2.2 CANADA
10.2.3 MEXICO
10.2.4 OTHERS
10.3 EUROPE
10.3.1 U.K.
10.3.2 GERMANY
10.3.3 FRANCE
10.3.4 OTHERS
10.4 APAC
10.4.1 JAPAN
10.4.2 CHINA
10.4.3 INDIA
10.4.4 OTHERS
10.5 ROW
10.5.1 MIDDLE EAST
10.5.2 AFRICA
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 TOP 5 PLAYERS IN BIOPHOTONICS MARKET- MARKET RANKING
11.3 COMPETITIVE SITUATION AND TRENDS
11.3.1 NEW PRODUCT LAUNCHES
11.3.2 AGREEMENTS, COLLABORATIONS, CONTRACTS, & PARTNERSHIPS
11.3.3 EXPANSIONS AND PATENTS
11.3.4 ACQUISITIONS
12 COMPANY PROFILES
(Overview, Products and Services, Financials, Strategy & Development)*
12.1 INTRODUCTION
12.2 AFFYMETRIX, INC.
12.3 ANDOR TECHNOLOGY LTD
12.4 BECTON, DICKINSON AND COMPANY
12.5 CARL ZEISS AG
12.6 FEI COMPANY
12.7 HAMAMATSU PHOTONICS K.K.
12.8 LUMENIS LTD.
12.9 OLYMPUS CORPORATION
12.10 PERKINELMER, INC.
12.11 ZECOTEK PHOTONICS INC.
*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies
13 APPENDIX
13.1 INSIGHTS OF INDUSTRY EXPERTS
13.2 DISCUSSION GUIDE
13.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
13.4 AVAILABLE CUSTOMIZATIONS
13.5 RELATED REPORT
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATION
1.6 MARKET STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of primary interviews
2.2 FACTOR ANALYSIS
2.2.1 INTRODUCTION
2.2.2 DEMAND-SIDE ANALYSIS
2.2.2.1 Rapid growth in the elderly population
2.2.3 SUPPLY-SIDE ANALYSIS
2.2.3.1 Poor customer perception
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
2.3.2 TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 BIOPHOTONICS MARKET OVERVIEW
4.2 BIOPHOTONICS MARKET, BY END-USE AND GEOGRAPHY
4.3 GEOGRAPHIC SNAPSHOT OF THE BIOPHOTONICS MARKET
4.4 BIOPHOTONICS MARKET, BY TECHNOLOGY (2015 – 2020)
4.5 SEE-THROUGH IMAGING BIOPHOTONICS MARKET, BY REGION
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET SEGMENTATION
5.2.1 BIOPHOTONICS MARKET, BY APPLICATION
5.2.2 BIOPHOTONICS MARKET, TECHNOLOGY
5.2.3 BIOPHOTONICS MARKET, BY END USE
5.2.4 BIOPHOTONICS MARKET, BY GEOGRAPHY
5.3 MARKET DYNAMICS
5.3.1 DRIVERS
5.3.1.1 Emergence of Nanotechnology
5.3.1.2 Significant technological advancements over the last few years
5.3.1.3 Increase in the demand for home-based POC devices
5.3.1.4 Aging population and growing lifestyle diseases
5.3.2 RESTRAINTS
5.3.2.1 Slow rate of commercialization
5.3.2.2 High cost involved in research and development
5.3.2.3 Reluctance toward the adoption of new treatment practices
5.3.3 OPPORTUNITIES
5.3.3.1 Emerging markets in the developing countries
5.3.3.2 The use of biophotonics in non-medical sectors
5.3.4 CHALLENGES
5.3.4.1 Government regulations and long certification & approval cycles
5.3.4.2 Pricing pressure in the point-of-care market
6 INDUSTRY INSIGHTS
6.1 INTRODUCTION
6.2 VALUE CHAIN ANALYSIS
6.3 INDUSTRY TRENDS
6.4 PORTER’S FIVE FORCES ANALYSIS
6.4.1 BARGAINING POWER OF SUPPLIERS
6.4.2 BARGAINING POWER OF BUYERS
6.4.3 THREAT OF NEW ENTRANTS
6.4.4 THREAT OF SUBSTITUTES
6.4.5 DEGREE OF COMPETITION
6.5 PEST ANALYSIS
6.5.1 POLITICAL FACTORS
6.5.2 ECONOMIC FACTORS
6.5.3 SOCIAL FACTORS
6.5.4 TECHNOLOGICAL FACTORS
7 BIOPHOTONICS MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 SEE-THROUGH IMAGING
7.3 INSIDE IMAGING (ENDOSCOPY)
7.4 SPECTROMOLECULAR
7.5 SURFACE IMAGING
7.6 MICROSCOPY
7.7 LIGHT THERAPY
7.8 BIOSENSORS
7.9 OTHERS
8 BIOPHOTONICS MARKET, BY TECHNOLOGY
8.1 INTRODUCTION
8.2 IN-VIVO
8.3 IN-VITRO
9 BIOPHOTONICS MARKET, BY END USE
9.1 INTRODUCTION
9.2 MEDICAL DIAGNOSTICS
9.3 MEDICAL THERAPEUTICS
9.4 TEST COMPONENTS
9.5 OTHER (NON-MEDICAL)
10 REGIONAL ANALYSIS
10.1 INTRODUCTION
10.2 AMERICAS
10.2.1 U.S.
10.2.2 CANADA
10.2.3 MEXICO
10.2.4 OTHERS
10.3 EUROPE
10.3.1 U.K.
10.3.2 GERMANY
10.3.3 FRANCE
10.3.4 OTHERS
10.4 APAC
10.4.1 JAPAN
10.4.2 CHINA
10.4.3 INDIA
10.4.4 OTHERS
10.5 ROW
10.5.1 MIDDLE EAST
10.5.2 AFRICA
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 TOP 5 PLAYERS IN BIOPHOTONICS MARKET- MARKET RANKING
11.3 COMPETITIVE SITUATION AND TRENDS
11.3.1 NEW PRODUCT LAUNCHES
11.3.2 AGREEMENTS, COLLABORATIONS, CONTRACTS, & PARTNERSHIPS
11.3.3 EXPANSIONS AND PATENTS
11.3.4 ACQUISITIONS
12 COMPANY PROFILES
(Overview, Products and Services, Financials, Strategy & Development)*
12.1 INTRODUCTION
12.2 AFFYMETRIX, INC.
12.3 ANDOR TECHNOLOGY LTD
12.4 BECTON, DICKINSON AND COMPANY
12.5 CARL ZEISS AG
12.6 FEI COMPANY
12.7 HAMAMATSU PHOTONICS K.K.
12.8 LUMENIS LTD.
12.9 OLYMPUS CORPORATION
12.10 PERKINELMER, INC.
12.11 ZECOTEK PHOTONICS INC.
*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies
13 APPENDIX
13.1 INSIGHTS OF INDUSTRY EXPERTS
13.2 DISCUSSION GUIDE
13.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
13.4 AVAILABLE CUSTOMIZATIONS
13.5 RELATED REPORT
LIST OF TABLES
Table 1 EMERGENCE OF NANOTECHNOLOGY AND TECHNOLOGICAL ADVANCEMENTS ARE THE KEY MARKET DRIVERS
Table 2 SLOW RATE OF COMMERCIALISATION AND HIGH COST OF R&D ARE MAJOR RESTRAINING FACTORS
Table 3 USE OF BIOPHOTONICS IN NON-MEDICAL APPLICATIONS IS A KEY OPPORTUNITY FOR THE COMPANIES
Table 4 GOVERNMENT REGULATIONS, LONG CERTIFICATION & APPROVAL CYCLES ARE THE MAJOR CHALLENGES FOR THE MARKET PLAYERS
Table 5 BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD BILLION)
Table 6 SEE-THROUGH IMAGING BIOPHOTONICS MARKET, BY REGION, 2013 - 2020 (USD BILLION)
Table 7 INSIDE IMAGING BIOPHOTONICS MARKET, BY REGION, 2013 - 2020 (USD BILLION)
Table 8 SPECTROMOLECULAR BIOPHOTONICS MARKET, BY REGION, 2013 - 2020 (USD BILLION)
Table 9 SURFACE IMAGING BIOPHOTONICS MARKET, BY REGION, 2013 - 2020 (USD MILLION)
Table 10 MICROSCOPY BIOPHOTONICS MARKET, BY REGION, 2013 - 2020 (USD MILLION)
Table 11 LIGHT THERAPY BIOPHOTONICS MARKET, BY REGION, 2013 - 2020 (USD MILLION)
Table 12 BIOSENSORS BIOPHOTONICS MARKET, BY REGION, 2013 - 2020 (USD MILLION)
Table 13 OTHER APPLICATIONS BIOPHOTONICS MARKET, BY REGION, 2013 - 2020 (USD MILLION)
Table 14 BIOPHOTONICS MARKET, BY TECHNOLOGY, 2013 - 2020 (USD BILLION)
Table 15 IN-VIVO BIOPHOTONICS MARKET, BY END USE, 2013 - 2020 (USD BILLION)
Table 16 IN-VITRO BIOPHOTONICS MARKET, BY END USE, 2013 - 2020 (USD BILLION)
Table 17 BIOPHOTONICS MARKET, BY END USE, 2013 - 2020 (USD BILLION)
Table 18 MEDICAL DIAGNOSTICS BIOPHOTONICS MARKET, BY TECHNOLOGY, 2013 - 2020 (USD BILLION)
Table 19 MEDICAL THERAPEUTICS BIOPHOTONICS MARKET, BY TECHNOLOGY, 2013 - 2020 (USD BILLION)
Table 20 TESTS & COMPONENTS BIOPHOTONICS MARKET, BY TECHNOLOGY, 2013 - 2020 (USD BILLION)
Table 21 BIOPHOTONICS MARKET, BY REGION, 2013 - 2020 (USD BILLION)
Table 22 THE AMERICAS BIOPHOTONICS MARKET, BY COUNTRY, 2013 - 2020 (USD BILLION)
Table 23 THE AMERICAS: BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD BILLION)
Table 24 THE AMERICAS: BIOPHOTONICS MARKET FOR SEE-THROUGH IMAGING, BY COUNTRY, 2013 - 2020 (USD BILLION)
Table 25 THE AMERICAS: BIOPHOTONICS MARKET FOR INSIDE IMAGING, BY COUNTRY, 2013 - 2020 (USD BILLION)
Table 26 THE AMERICAS: BIOPHOTONICS MARKET FOR SPECTROMOLECULAR, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 27 THE AMERICAS: BIOPHOTONICS MARKET FOR SURFACE IMAGING, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 28 THE AMERICAS: BIOPHOTONICS MARKET FOR MICROSCOPY, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 29 THE AMERICAS: BIOPHOTONICS MARKET FOR LIGHT THERAPY, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 30 THE AMERICAS: BIOPHOTONICS MARKET FOR BIOSENSORS, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 31 THE AMERICAS: BIOPHOTONICS MARKET FOR OTHER SECTORS, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 32 U.S.: BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD BILLION)
Table 33 CANADA: BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD BILLION)
Table 34 MEXICO: BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD MILLION)
Table 35 OTHERS BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD MILLION)
Table 36 EUROPE: BIOPHOTONICS MARKET, BY COUNTRY, 2013 - 2020 (USD BILLION)
Table 37 EUROPE: BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD BILLION)
Table 38 EUROPE: BIOPHOTONICS MARKET FOR SEE-THROUGH IMAGING, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 39 EUROPE: BIOPHOTONICS MARKET FOR INSIDE IMAGING, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 40 EUROPE: BIOPHOTONICS MARKET FOR SPECTROMOLECULAR, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 41 EUROPE: BIOPHOTONICS MARKET FOR SURFACE IMAGING, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 42 EUROPE: BIOPHOTONICS MARKET FOR MICROSCOPY, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 43 EUROPE: BIOPHOTONICS MARKET FOR LIGHT THERAPY, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 44 EUROPE: BIOPHOTONICS MARKET FOR BIOSENSORS, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 45 EUROPE: BIOPHOTONICS MARKET FOR OTHER SECTORS, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 46 U.K.: BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD MILLION)
Table 47 GERMANY: BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD MILLION)
Table 48 FRANCE: BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD MILLION)
Table 49 OTHERS BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD MILLION)
Table 50 APAC: BIOPHOTONICS MARKET, BY COUNTRY, 2013 - 2020 (USD BILLION)
Table 51 APAC: BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD BILLION)
Table 52 APAC: BIOPHOTONICS MARKET FOR SEE-THROUGH IMAGING, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 53 APAC: BIOPHOTONICS MARKET FOR INSIDE IMAGING, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 54 APAC: BIOPHOTONICS MARKET FOR SPECTROMOLECULAR, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 55 APAC: BIOPHOTONICS MARKET FOR SURFACE IMAGING, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 56 APAC: BIOPHOTONICS MARKET FOR MICROSCOPY, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 57 APAC: BIOPHOTONICS MARKET FOR LIGHT THERAPY, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 58 APAC: BIOPHOTONICS MARKET FOR BIOSENSORS, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 59 APAC: BIOPHOTONICS MARKET FOR OTHER SECTORS, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 60 JAPAN: BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD MILLION)
Table 61 CHINA: BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD MILLION)
Table 62 INDIA: BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD MILLION)
Table 63 OTHERS BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD BILLION)
Table 64 ROW: BIOPHOTONICS MARKET, BY COUNTRY, 2013 - 2020 (USD BILLION)
Table 65 ROW BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD MILLION)
Table 66 ROW: BIOPHOTONICS MARKET FOR SEE-THROUGH IMAGING, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 67 ROW: BIOPHOTONICS MARKET FOR INSIDE IMAGING, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 68 ROW: BIOPHOTONICS MARKET FOR SPECTROMOLECULAR, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 69 ROW: BIOPHOTONICS MARKET FOR SURFACE IMAGING, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 70 ROW: BIOPHOTONICS MARKET FOR MICROSCOPY, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 71 ROW: BIOPHOTONICS MARKET FOR LIGHT THERAPY, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 72 ROW: BIOPHOTONICS MARKET FOR BIOSENSORS, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 73 ROW: BIOPHOTONICS MARKET FOR OTHER SECTORS, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 74 THE MIDDLE EAST: BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD MILLION)
Table 75 AFRICA: BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD MILLION)
Table 76 BIOPHOTONICS MARKET: KEY PLAYERS, 2014
Table 77 NEW PRODUCT LAUNCHES
Table 78 AGREEMENTS, COLLABORATIONS, CONTRACTS, & PARTNERSHIPS
Table 79 EXPANSIONS AND PATENTS
Table 80 ACQUISITIONS
Table 1 EMERGENCE OF NANOTECHNOLOGY AND TECHNOLOGICAL ADVANCEMENTS ARE THE KEY MARKET DRIVERS
Table 2 SLOW RATE OF COMMERCIALISATION AND HIGH COST OF R&D ARE MAJOR RESTRAINING FACTORS
Table 3 USE OF BIOPHOTONICS IN NON-MEDICAL APPLICATIONS IS A KEY OPPORTUNITY FOR THE COMPANIES
Table 4 GOVERNMENT REGULATIONS, LONG CERTIFICATION & APPROVAL CYCLES ARE THE MAJOR CHALLENGES FOR THE MARKET PLAYERS
Table 5 BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD BILLION)
Table 6 SEE-THROUGH IMAGING BIOPHOTONICS MARKET, BY REGION, 2013 - 2020 (USD BILLION)
Table 7 INSIDE IMAGING BIOPHOTONICS MARKET, BY REGION, 2013 - 2020 (USD BILLION)
Table 8 SPECTROMOLECULAR BIOPHOTONICS MARKET, BY REGION, 2013 - 2020 (USD BILLION)
Table 9 SURFACE IMAGING BIOPHOTONICS MARKET, BY REGION, 2013 - 2020 (USD MILLION)
Table 10 MICROSCOPY BIOPHOTONICS MARKET, BY REGION, 2013 - 2020 (USD MILLION)
Table 11 LIGHT THERAPY BIOPHOTONICS MARKET, BY REGION, 2013 - 2020 (USD MILLION)
Table 12 BIOSENSORS BIOPHOTONICS MARKET, BY REGION, 2013 - 2020 (USD MILLION)
Table 13 OTHER APPLICATIONS BIOPHOTONICS MARKET, BY REGION, 2013 - 2020 (USD MILLION)
Table 14 BIOPHOTONICS MARKET, BY TECHNOLOGY, 2013 - 2020 (USD BILLION)
Table 15 IN-VIVO BIOPHOTONICS MARKET, BY END USE, 2013 - 2020 (USD BILLION)
Table 16 IN-VITRO BIOPHOTONICS MARKET, BY END USE, 2013 - 2020 (USD BILLION)
Table 17 BIOPHOTONICS MARKET, BY END USE, 2013 - 2020 (USD BILLION)
Table 18 MEDICAL DIAGNOSTICS BIOPHOTONICS MARKET, BY TECHNOLOGY, 2013 - 2020 (USD BILLION)
Table 19 MEDICAL THERAPEUTICS BIOPHOTONICS MARKET, BY TECHNOLOGY, 2013 - 2020 (USD BILLION)
Table 20 TESTS & COMPONENTS BIOPHOTONICS MARKET, BY TECHNOLOGY, 2013 - 2020 (USD BILLION)
Table 21 BIOPHOTONICS MARKET, BY REGION, 2013 - 2020 (USD BILLION)
Table 22 THE AMERICAS BIOPHOTONICS MARKET, BY COUNTRY, 2013 - 2020 (USD BILLION)
Table 23 THE AMERICAS: BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD BILLION)
Table 24 THE AMERICAS: BIOPHOTONICS MARKET FOR SEE-THROUGH IMAGING, BY COUNTRY, 2013 - 2020 (USD BILLION)
Table 25 THE AMERICAS: BIOPHOTONICS MARKET FOR INSIDE IMAGING, BY COUNTRY, 2013 - 2020 (USD BILLION)
Table 26 THE AMERICAS: BIOPHOTONICS MARKET FOR SPECTROMOLECULAR, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 27 THE AMERICAS: BIOPHOTONICS MARKET FOR SURFACE IMAGING, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 28 THE AMERICAS: BIOPHOTONICS MARKET FOR MICROSCOPY, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 29 THE AMERICAS: BIOPHOTONICS MARKET FOR LIGHT THERAPY, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 30 THE AMERICAS: BIOPHOTONICS MARKET FOR BIOSENSORS, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 31 THE AMERICAS: BIOPHOTONICS MARKET FOR OTHER SECTORS, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 32 U.S.: BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD BILLION)
Table 33 CANADA: BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD BILLION)
Table 34 MEXICO: BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD MILLION)
Table 35 OTHERS BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD MILLION)
Table 36 EUROPE: BIOPHOTONICS MARKET, BY COUNTRY, 2013 - 2020 (USD BILLION)
Table 37 EUROPE: BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD BILLION)
Table 38 EUROPE: BIOPHOTONICS MARKET FOR SEE-THROUGH IMAGING, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 39 EUROPE: BIOPHOTONICS MARKET FOR INSIDE IMAGING, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 40 EUROPE: BIOPHOTONICS MARKET FOR SPECTROMOLECULAR, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 41 EUROPE: BIOPHOTONICS MARKET FOR SURFACE IMAGING, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 42 EUROPE: BIOPHOTONICS MARKET FOR MICROSCOPY, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 43 EUROPE: BIOPHOTONICS MARKET FOR LIGHT THERAPY, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 44 EUROPE: BIOPHOTONICS MARKET FOR BIOSENSORS, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 45 EUROPE: BIOPHOTONICS MARKET FOR OTHER SECTORS, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 46 U.K.: BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD MILLION)
Table 47 GERMANY: BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD MILLION)
Table 48 FRANCE: BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD MILLION)
Table 49 OTHERS BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD MILLION)
Table 50 APAC: BIOPHOTONICS MARKET, BY COUNTRY, 2013 - 2020 (USD BILLION)
Table 51 APAC: BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD BILLION)
Table 52 APAC: BIOPHOTONICS MARKET FOR SEE-THROUGH IMAGING, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 53 APAC: BIOPHOTONICS MARKET FOR INSIDE IMAGING, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 54 APAC: BIOPHOTONICS MARKET FOR SPECTROMOLECULAR, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 55 APAC: BIOPHOTONICS MARKET FOR SURFACE IMAGING, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 56 APAC: BIOPHOTONICS MARKET FOR MICROSCOPY, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 57 APAC: BIOPHOTONICS MARKET FOR LIGHT THERAPY, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 58 APAC: BIOPHOTONICS MARKET FOR BIOSENSORS, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 59 APAC: BIOPHOTONICS MARKET FOR OTHER SECTORS, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 60 JAPAN: BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD MILLION)
Table 61 CHINA: BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD MILLION)
Table 62 INDIA: BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD MILLION)
Table 63 OTHERS BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD BILLION)
Table 64 ROW: BIOPHOTONICS MARKET, BY COUNTRY, 2013 - 2020 (USD BILLION)
Table 65 ROW BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD MILLION)
Table 66 ROW: BIOPHOTONICS MARKET FOR SEE-THROUGH IMAGING, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 67 ROW: BIOPHOTONICS MARKET FOR INSIDE IMAGING, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 68 ROW: BIOPHOTONICS MARKET FOR SPECTROMOLECULAR, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 69 ROW: BIOPHOTONICS MARKET FOR SURFACE IMAGING, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 70 ROW: BIOPHOTONICS MARKET FOR MICROSCOPY, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 71 ROW: BIOPHOTONICS MARKET FOR LIGHT THERAPY, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 72 ROW: BIOPHOTONICS MARKET FOR BIOSENSORS, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 73 ROW: BIOPHOTONICS MARKET FOR OTHER SECTORS, BY COUNTRY, 2013 - 2020 (USD MILLION)
Table 74 THE MIDDLE EAST: BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD MILLION)
Table 75 AFRICA: BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD MILLION)
Table 76 BIOPHOTONICS MARKET: KEY PLAYERS, 2014
Table 77 NEW PRODUCT LAUNCHES
Table 78 AGREEMENTS, COLLABORATIONS, CONTRACTS, & PARTNERSHIPS
Table 79 EXPANSIONS AND PATENTS
Table 80 ACQUISITIONS
LIST OF FIGURES
Figure 1 BIOPHOTONICS MARKET: RESEARCH DESIGN
Figure 2 COUNTRYWISE PERCENTAGE OF AGING POPULATION (2004 VS 2014)
Figure 3 BOTTOM-UP APPROACH
Figure 4 TOP-DOWN APPROACH
Figure 5 DATA TRIANGULATION METHODOLOGY
Figure 6 BIOPHOTONICS MARKET SNAPSHOT: APPLICATION IN SEE-THROUGH IMAGING ARE EXPECTED TO LEAD THE MARKET
Figure 7 OTHER END USES SUCH AS BIOMETRICS AND BIOSENSING EXPECTEDTO WITNESS THE HIGHEST GROWTH RATE
Figure 8 GLOBAL BIOPHOTONICS MARKET, BY TECHNOLOGY, 2014
Figure 9 GLOBAL BIOPHOTONICS MARKET, BY REGION, 2014
Figure 10 BIOPHOTONICS MARKET TO SHOWCASE LUCRATIVE GROWTH OPPORTUNITIES IN NON-MEDICAL SECTORS
Figure 11 MEDICAL DIAGNOSTICS SEGMENT TO HOLD THE LARGEST MARKET SHARE IN 2015
Figure 12 COUNTRIES IN APAC EXPECTED TO WITNESS HIGH GROWTH RATE DURING THE FORECAST PERIOD
Figure 13 OTHER (NON-MEDICAL) SECTORS TO WITNESS HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
Figure 14 AMERICAS EXPECTED TO BE THE LEADING MARKET FOR SEE-THROUGH IMAGING TILL 2020
Figure 15 BIOPHOTONICS MARKET SEGMENTATION
Figure 16 MARKET, BY APPLICATION
Figure 17 MARKET, BY TECHNOLOGY
Figure 18 BIOPHOTONICS MARKET: BY END USE
Figure 19 BIOPHOTONICS MARKET: BY GEOGRAPHY
Figure 20 EMERGENCE OF NANOTECHNOLOGY AND TECHNOLOGICAL ADVANCEMENTS ARE THE KEY MARKET DRIVERS
Figure 21 NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET, BY APPLICATION
Figure 22 PERCENTAGE OF WORLD POPULATION, BY COUNTRY, 2014
Figure 23 VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED DURING R&D AND MANUFACTURING STAGES
Figure 24 INDUSTRY TRENDS
Figure 25 PORTER’S FIVE FORCES ANALYSIS: BIOPHOTONICS MARKET
Figure 26 BIOPHOTONICS MARKET, BY APPLICATION
Figure 27 BIOPHOTONICS MARKET, BY TECHNOLOGY
Figure 28 BIOPHOTONICS MARKET, BY END USE
Figure 29 GEOGRAPHICAL SNAPSHOT: APAC WAS THE FASTEST-GROWING MARKET FOR BIOPHOTONICS, 2014
Figure 30 THE AMERICAS: MARKET SNAPSHOT
Figure 31 EUROPEAN MARKET SNAPSHOT
Figure 32 APAC MARKET SNAPSHOT
Figure 33 ROW MARKET SNAPSHOT
Figure 34 COMPANIES ADOPTED NEW PRODUCT LAUNCHES AS THE KEY GROWTH STRATEGY OVER THE LAST FOUR YEARS (2012-2015)
Figure 35 BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES HAS BEEN THE KEY STRATEGY
Figure 36 GEOGRAPHIC REVENUE MIX OF MAJOR PLAYERS
Figure 37 AFFYMETRIX, INC.: COMPANY SNAPSHOT
Figure 38 AFFYMETRIX, INC.: SWOT ANALYSIS
Figure 39 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
Figure 40 BECTON, DICKINSON AND COMPANY: SWOT ANALYSIS
Figure 41 CARL ZEISS AG: COMPANY SNAPSHOT
Figure 42 CARL ZEISS AG: SWOT ANALYSIS
Figure 43 FEI COMPANY: COMPANY SNAPSHOT
Figure 44 HAMAMATSU PHOTONICS K.K.: COMPANY SNAPSHOT
Figure 45 HAMAMATSU PHOTONICS K.K.: SWOT ANALYSIS
Figure 46 LUMENIS LTD.: COMPANY SNAPSHOT
Figure 47 OLYMPUS CORPORATION: COMPANY SNAPSHOT
Figure 48 OLYMPUS CORPORATION: SWOT ANALYSIS
Figure 49 PERKINELMER, INC.: COMPANY SNAPSHOT
Figure 50 ZECOTEK PHOTONICS INC.: COMPANY SNAPSHOT
Figure 1 BIOPHOTONICS MARKET: RESEARCH DESIGN
Figure 2 COUNTRYWISE PERCENTAGE OF AGING POPULATION (2004 VS 2014)
Figure 3 BOTTOM-UP APPROACH
Figure 4 TOP-DOWN APPROACH
Figure 5 DATA TRIANGULATION METHODOLOGY
Figure 6 BIOPHOTONICS MARKET SNAPSHOT: APPLICATION IN SEE-THROUGH IMAGING ARE EXPECTED TO LEAD THE MARKET
Figure 7 OTHER END USES SUCH AS BIOMETRICS AND BIOSENSING EXPECTEDTO WITNESS THE HIGHEST GROWTH RATE
Figure 8 GLOBAL BIOPHOTONICS MARKET, BY TECHNOLOGY, 2014
Figure 9 GLOBAL BIOPHOTONICS MARKET, BY REGION, 2014
Figure 10 BIOPHOTONICS MARKET TO SHOWCASE LUCRATIVE GROWTH OPPORTUNITIES IN NON-MEDICAL SECTORS
Figure 11 MEDICAL DIAGNOSTICS SEGMENT TO HOLD THE LARGEST MARKET SHARE IN 2015
Figure 12 COUNTRIES IN APAC EXPECTED TO WITNESS HIGH GROWTH RATE DURING THE FORECAST PERIOD
Figure 13 OTHER (NON-MEDICAL) SECTORS TO WITNESS HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
Figure 14 AMERICAS EXPECTED TO BE THE LEADING MARKET FOR SEE-THROUGH IMAGING TILL 2020
Figure 15 BIOPHOTONICS MARKET SEGMENTATION
Figure 16 MARKET, BY APPLICATION
Figure 17 MARKET, BY TECHNOLOGY
Figure 18 BIOPHOTONICS MARKET: BY END USE
Figure 19 BIOPHOTONICS MARKET: BY GEOGRAPHY
Figure 20 EMERGENCE OF NANOTECHNOLOGY AND TECHNOLOGICAL ADVANCEMENTS ARE THE KEY MARKET DRIVERS
Figure 21 NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET, BY APPLICATION
Figure 22 PERCENTAGE OF WORLD POPULATION, BY COUNTRY, 2014
Figure 23 VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED DURING R&D AND MANUFACTURING STAGES
Figure 24 INDUSTRY TRENDS
Figure 25 PORTER’S FIVE FORCES ANALYSIS: BIOPHOTONICS MARKET
Figure 26 BIOPHOTONICS MARKET, BY APPLICATION
Figure 27 BIOPHOTONICS MARKET, BY TECHNOLOGY
Figure 28 BIOPHOTONICS MARKET, BY END USE
Figure 29 GEOGRAPHICAL SNAPSHOT: APAC WAS THE FASTEST-GROWING MARKET FOR BIOPHOTONICS, 2014
Figure 30 THE AMERICAS: MARKET SNAPSHOT
Figure 31 EUROPEAN MARKET SNAPSHOT
Figure 32 APAC MARKET SNAPSHOT
Figure 33 ROW MARKET SNAPSHOT
Figure 34 COMPANIES ADOPTED NEW PRODUCT LAUNCHES AS THE KEY GROWTH STRATEGY OVER THE LAST FOUR YEARS (2012-2015)
Figure 35 BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES HAS BEEN THE KEY STRATEGY
Figure 36 GEOGRAPHIC REVENUE MIX OF MAJOR PLAYERS
Figure 37 AFFYMETRIX, INC.: COMPANY SNAPSHOT
Figure 38 AFFYMETRIX, INC.: SWOT ANALYSIS
Figure 39 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
Figure 40 BECTON, DICKINSON AND COMPANY: SWOT ANALYSIS
Figure 41 CARL ZEISS AG: COMPANY SNAPSHOT
Figure 42 CARL ZEISS AG: SWOT ANALYSIS
Figure 43 FEI COMPANY: COMPANY SNAPSHOT
Figure 44 HAMAMATSU PHOTONICS K.K.: COMPANY SNAPSHOT
Figure 45 HAMAMATSU PHOTONICS K.K.: SWOT ANALYSIS
Figure 46 LUMENIS LTD.: COMPANY SNAPSHOT
Figure 47 OLYMPUS CORPORATION: COMPANY SNAPSHOT
Figure 48 OLYMPUS CORPORATION: SWOT ANALYSIS
Figure 49 PERKINELMER, INC.: COMPANY SNAPSHOT
Figure 50 ZECOTEK PHOTONICS INC.: COMPANY SNAPSHOT
